Future Strategy

Lupus Capital PLC 21 November 2002 21 November 2002 PRESS RELEASE Lupus Capital plc - Future Strategy The board of Lupus Capital plc ('Lupus' or the 'Company'), together with its advisers, has been giving, as stated in its circular to shareholders dated 5 November 2002, further detailed consideration to the structure of the Company. The board of Lupus (the 'Board') has now reached the following conclusions. The Board considers that there are two points to be recognised: • Lupus's business model is a very effective means of meeting the strategic challenges encountered by small and medium sized companies. The relevance of such a business model is increasing and the Board notes that within the last fortnight two groups have announced similar plans. • The depressed state of the financial markets - and the demands for liquidity and cash - have meant that fewer and fewer institutional investors have an appetite for investing in small public companies and hence a desire to invest in a company of Lupus's size and nature. This is in contrast to the position of a large number of individual shareholders who are supportive of smaller companies including Lupus. However, no public company wishing to grow - as Lupus does - can flourish without sustained support from institutional investors. The Board is, therefore, announcing some far-reaching decisions. As an initial measure the Board intends to launch, subject to shareholder approval, a tender offer to return up to £2 million to shareholders by the end of January 2003. This is in recognition of the short-term needs for cash and liquidity of some shareholders. The Board intends formally to announce the tender offer and post the necessary circular to shareholders before Christmas with a view to holding the required extraordinary general meeting during January 2003. Discussions with potential buyers continue in relation to the sale of Gall Thomson Environmental Limited ('Gall Thomson'). If a sale of Gall Thomson is achieved (subject to shareholder approval), one of two options will be chosen to return value to shareholders: • All other assets of the Company will be sold, the Company effectively wound down and all net proceeds returned to shareholders as quickly and prudently as possible. • Alternatively, in the unlikely event of significantly more favourable financial market conditions for small companies - and particularly for companies like Lupus - becoming apparent during the early part of next year, the Board would consider a further tender offer returning part of the net proceeds from the sale of Gall Thomson. This would allow those who did not wish to participate in Lupus's future to sell their shares while those shareholders who shared the Board's enthusiasm for its strategy would have the option to continue to participate in the Company's future. In the event that a satisfactory offer for Gall Thomson is not forthcoming, the Board is prepared to pursue other options to maximise shareholder value. The Board will report back to shareholders as soon as possible and no later than the announcement of Lupus's results for the year to 31 December 2002, scheduled for late March 2003. As a further sign of the Board's commitment to resolving the Company's future in the best interests of shareholders, the executive directors of the Company and the other members of the management team will convert their rolling twelve month employment contracts to twelve month fixed employment contracts to take effect from 1 December 2002. The Board repeats its recommendation that shareholders vote against all the resolutions proposed by the requisitionists at the Extraordinary General Meeting to be held on Thursday, 28 November 2002. - Ends - Lupus Capital plc Tel: 020 7976 8000 Charles Ryder, Chief Executive www.lupuscapital.com James Orr, Finance Director Oriel Securities Limited Tel: 020 7710 7600 Simon Bragg/Adrian McMillan Merlin Financial Tel: 020 7606 1244 Paul Downes/Tom Randell This information is provided by RNS The company news service from the London Stock Exchange

Companies

Tyman (TYMN)
UK 100

Latest directors dealings